Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
Pharmaceutical Technology on MSN
FDA seeks permanent future for rare pediatric priority review vouchersThe rare disease framework has had a turbulent past few years, with the FDA looking to create regulatory stability.
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story FDA commissioner credits himself with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results